Impact of Primary Care COPD Screening Strategies on the Smoking Cessation Process (DISCO-SET)

NCT04833933 | Completed

• 1 other identifier: 35RC21_9742_DISCO-SET
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 12

Brief Summary

The general practitioner is confronted with unselected smokers whose attempts to quit smoking are often repeated over time before leading to a definitive cessation. Each year, 3-5% of smokers succeed in quitting in the general population. The corollary is that the majority of smokers are in a situation of failure in their attempt to quit: 33% declared during the 2019 French Health Barometer to have made an attempt of at least 7 days in the past year. Thus, this status of "smoker" can cover a wide variety of situations: no attempt to stop smoking, attempt(s) of more or less clinical significance, previous support or not by a health professional, etc. Currently, the HAS recommendations do not determine a specific course of action for these smokers, whose experiences may be very different. It could therefore be interesting to objectivize the smoking cessation process of these patients who have or have not succeeded in quitting, in order to deduce profiles of smokers according to their previous smoking cessation experiences. Furthermore, the choice and relevance of the cessation criteria used are debated. Following the randomized controlled trial DISCO on COPD screening interventions in primary care (3 intervention arms, 1 control arm), the investigators will carry out a pilot cross-sectional survey on the cessation process of smokers during the 2 years following their participation, evaluating the incidence and modalities of cessation attempts of smokers belonging to an age group at risk of COPD (40-80 years) and who initially consulted their general practitioner for any reason 2 years ago at the time of their inclusion. The impact on future management could be the personalization of cessation advice given to smokers according to quantitative and qualitative indicators specific to their experience, their previous history of smoking cessation, their health situation and socio-demographic characteristics. Eventually, a gradation of the levels of support offered to patients in general practice on the basis of predictive factors of smoking cessation could be studied. The investigators hypothesize that participation in COPD screening with the GP may be associated with patient progress in quitting smoking. This pilot study will be conducted on a random sample of 120 participants from the subgroup of 544 patients who were smokers at inclusion in DISCO.

Conditions

Smoking Cessation; Pulmonary Disease, Chronic Obstructive

Keywords

Tobacco use cessation devices; Electronic Nicotine Delivery Systems; Cross-Sectional Studies; Smokers; Primary Care

Outcome Measures

Primary Outcomes (1)

• Percentage of smoking patients with at least 1 episode of smoking cessation attempts of at least 28 days since inclusion in the DISCO study.

  2 years

Secondary Outcomes (16)

• Smoking cessation of at least 7 days

  2 years

• Smoking cessation of at least 28 days

  2 years

• Smoking cessation of at least 6 months

  2 years

• Smoking cessation attempts of 7 days

  2 years

• Smoking cessation attempts of 28 days

  2 years

Study Arms (4)

Control group

Initially in DISCO trial : no intervention, usual care In DISCO-SET trial : survey (the same in the 4 groups)

Other: Phone survey about smoking cessation process since intervention in DISCO trial

Questionnaire

Initially in DISCO trial : Targeted screening of COPD by GPs via the GOLD / HAS questionnaire. The questionnaire includes 4 questions for patients over 40. At least one positive response is an indication to perform a spirometry. In DISCO-SET trial : survey (the same in the 4 groups)

Other: Phone survey about smoking cessation process since intervention in DISCO trial

Coordination

Initially in DISCO trial : Information of the GPs of the existence of a coordination of the care of proximity to facilitate the access to the spirometry (identification of a referent specialist, making appointments). In DISCO-SET trial : survey (the same in the 4 groups)

Other: Phone survey about smoking cessation process since intervention in DISCO trial

Questionnaire + Coordination

Initially in DISCO trial : * Targeted screening of COPD by GPs via the GOLD / HAS questionnaire. The questionnaire includes 4 questions for patients over 40. At least one positive response is an indication to perform a spirometry. * Information of the GPs of the existence of a coordination of the care of proximity to facilitate the access to the spirometry (identification of a referent specialist, making appointments). In DISCO-SET trial : survey (the same in the 4 groups)

Other: Phone survey about smoking cessation process since intervention in DISCO trial

Interventions

Phone survey about smoking cessation process since intervention in DISCO trial OTHER

We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.

Control group; Coordination; Questionnaire; Questionnaire + Coordination

Eligibility Criteria

• Age: 40 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Random sample of 120 patients from the subgroup of 544 patients who were active smokers at inclusion in the DISCO study two years ago

You may qualify if:

• No objection to participate in the study,
• Patient still followed in the active file of general practitioners' offices (GP).
• Patient's telephone and postal details available

You may not qualify if:

• Patient not physically or mentally able to complete the phone survey,
• Patient deceased,
• Patient not reachable despite 5 phone calls and message left on answering machine.
• Patient under curatorship, guardianship or safeguard of justice

Sponsors & Collaborators

• Rennes University Hospital: lead

Study Sites (12)

Emmanuelle FOURE-AMELOT

Bédée, Brittany Region, 35137, France

Location

Béatrice NEGARET

Breteil, Brittany Region, 35160, France

Location

Lucie DELATTE

Janzé, Brittany Region, 35150, France

Location

Marie BROSSET

Miniac-Morvan, Brittany Region, 35540, France

Location

Antoine MOUTEL

Redon, Brittany Region, 35600, France

Location

Anna JARNO-JOSSE

Rennes, Brittany Region, 35000, France

Location

Hoël CHARBONNEL

Rennes, Brittany Region, 35000, France

Location

Romain NIFENECKER

Rennes, Brittany Region, 35000, France

Location

Jean-Philippe DUGUEY

St-Malo, Brittany Region, 35400, France

Location

Laurent LENOBLE

Sulniac, Brittany Region, 56250, France

Location

Lucie MURGALE

Talensac, Brittany Region, 35160, France

Location

Marieke SALACROUP

Tremblay, Brittany Region, 35460, France

Location

MeSH Terms

Conditions

Smoking Cessation; Pulmonary Disease, Chronic Obstructive; Vaping

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Smoking

Study Officials

• Bruno LAVIOLLE, PhD

  Rennes UH

  STUDY CHAIR

• Anthony CHAPRON, PhD

  Faculty of medicine of rennes

  PRINCIPAL INVESTIGATOR

• Anthony CHAPRON, PhD

  Faculty of medicine of rennes

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 2, 2021
• First Posted: April 6, 2021
• Study Start: April 7, 2021
• Primary Completion: July 7, 2021
• Study Completion: July 7, 2021
• Last Updated: November 17, 2021

Record last verified: 2021-11

Locations

FR (12)